Veterinary medicines enter animal care settings through many routes: prescriptions dispensed in clinics, stock held by shelters, treatments supplied to foster carers, and products purchased by owners for home use. Not all of that medicine is used. Courses are stopped, prescriptions change, animals are rehomed or euthanised, packaging is damaged, and surplus stock accumulates. The result is a steady flow of unused, expired and returned veterinary medicines that must be stored, segregated and disposed of safely.
That flow is often managed informally. A cupboard may hold expired stock, a client may keep leftover tablets in case they are needed again, and a shelter may receive donated medicines without a complete history. Individually, these are small operational details. Collectively, they raise questions about safety, environmental responsibility, record-keeping and regulatory consistency. The Global Animal Care Awards 2026 provide a useful framework for this issue, because the category recognises practical, cross-sector approaches to animal welfare, and medicine waste sits at the intersection of clinical practice, client communication, procurement and environmental health.
Why Medicine Waste Accumulates
Veterinary medicine waste is not limited to products that have passed their expiry date. It includes medicines returned by owners, partially used containers, products withdrawn from use, stock that cannot be verified, and donations that arrive without adequate packaging or storage history. In clinics, inventory control is rarely perfect. In shelters and charities, space is constrained and stock may be donated by supporters or transferred between sites. In owner homes, the medicine cabinet can become a long-term store for treatments no longer relevant.
The consequences are practical. Accumulated medicines take up storage space and can be confused with current stock. They may be accessible to children, pets or visitors. Expired products may be used in error. Returned medicines may not be suitable for reuse even when the packaging appears intact. And improper disposal, whether through drains, household waste or informal routes, can place active ingredients into the environment in ways waste systems are not designed to manage.
Rules vary by jurisdiction and product type. Some medicines require specific disposal routes, controlled drugs often carry additional requirements, and the legal status of returned stock may differ from that of unused stock in practice. Animal care organisations therefore need procedures that reflect their own regulatory setting rather than a generic approach.
Internal Protocols and Disposal Routes
A credible medicine waste programme begins with clear internal ownership. Someone should be responsible for the process, and staff should know where medicines go when they are returned, withdrawn, expired or damaged. Segregation at the point of generation is central. Returning a medicine to a designated container immediately is safer than leaving it in a consulting room, kennel office or storage cupboard where it can be mixed with active stock.
Protocols typically cover:
- A written procedure for identifying, segregating, storing and transferring medicines for disposal.
- Secure interim storage separate from usable stock, accessible only to authorised staff.
- Clear labelling of waste containers and records showing what was collected, when and by whom.
- Authorised waste contractors or take-back arrangements appropriate to the product and jurisdiction.
- Staff training covering handling, documentation, spill response and acceptance limits.
- Periodic review of stock, expiry dates and returns to identify problems early.
Record-keeping matters because waste is part of the medicines supply chain. Records support accountability, help respond to queries, and show that disposal followed an agreed route. They also reveal patterns: repeated over-ordering, frequent returns of a particular product, or stock that consistently expires before use.
Client Communication and Home Storage
Much veterinary medicine waste sits outside the clinic. Owners may stop a course early, keep leftover tablets for later, or store medicines without checking expiry dates. Some may flush unwanted liquids or place them in household waste when no alternative has been explained. Client communication is therefore part of making waste policy work, not a soft addition to it.
Guidance should be practical and product-specific. Owners need to know whether a medicine can be returned to the practice, whether a take-back scheme exists, and what to do if neither route is available. Owners should be discouraged from sharing medicines between animals, using leftovers without veterinary advice, or keeping products indefinitely. Dispensing conversations, repeat prescription reviews and written instructions can reinforce the message.
Prescribing and dispensing practices also influence the volume of waste. Where clinically appropriate, avoiding unnecessary pack sizes, reviewing repeat prescriptions and checking owner understanding of the treatment plan can reduce unused medicine. The aim is not to withhold treatment but to align supply with realistic use.
Shelters, Charities and Surplus Stock
Shelters and charities face particular difficulties: medicines may arrive through donation, transfer or informal support. A donated product may lack complete packaging, prescription history or evidence of correct storage. It may be expired, partly used or unsuitable for the animals in care. Good intentions do not remove the need for assessment.
Organisations should have a clear policy on donated and surplus medicines. Products should be quarantined on arrival, checked by a qualified person, and accepted only where their identity, condition and legal status can be established. Unverified medicines should not enter routine stock. They should be stored securely and disposed of appropriately.
The same discipline applies to foster carers and satellite sites. If medicines are sent home with an animal, the organisation should explain what to do with remainders. Otherwise, surplus stock disperses into homes and is harder to recover.
Stewardship, Procurement and a Compliance Culture
Medicine waste planning overlaps with antimicrobial stewardship and One Health, which links human health, animal health and the environment. Unused antibiotics are a particular concern: every avoidable course is a missed opportunity to reduce selective pressure on bacteria. Responsible prescribing, owner compliance and supply control contribute to stewardship, and returns data can show where unused medicines come from.
Procurement is part of the same picture. Stock control, expiry tracking and ordering discipline reduce medicine waste. Smaller pack sizes, where clinically suitable, can help. So can a clear returns process for unwanted products. These operational measures support a compliance culture in which medicine waste is a managed risk, not an inconvenient by-product.
The Global Animal Care Awards 2026 recognise practical, cross-sector work that improves animal welfare. Medicine waste fits that description: it cannot be solved by clinicians alone. It requires procurement staff, practice managers, shelter teams, waste contractors and clients to understand their roles. Organisations that build clear protocols, communicate with owners and review stock practices are better placed to reduce waste, protect staff and animals, and demonstrate environmental responsibility. The challenge is not simply disposal, but making the whole lifecycle of a veterinary medicine visible, accountable and properly managed.
